You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Baseline characteristics (median (IQR)) of women with proteinuria at follow-up

From: Short term sequelae of preeclampsia: a single center cohort study

  No UPE (n = 134) UPE > 0.11 (n = 66) p-value No UPE (n = 184) UPE ≥30 (n = 16) p-value
Age 31 (28–35) 35 (28–38) 0.16 32 (29–36) 34 (25–38) 0.80
Onset (d) 260 (238–272) 258 (246–272) 0.61 259 (240–272) 266 (248–279) 0.29
Early onset 24.8% (32/129) 14.1% (9/64) 0.09 22.6% (40/177) 6.25% (1/16) 0.13
Nulliparous 75.2% (100/133) 73.9% (48/65) 0.84 73.6% (134/182) 87.5% (14/16) 0.22
Time to f/u (d) 183 (157–191) 172 (138–187) 0.06 180 (154–190) 160 (114–195) 0.42
MP 12.7% (17/134) 15.2% (10/66) 0.61 14.1% (26/184) 6.3% (1/16) 0.34
IVF 4.5% (6/134) 10.6% (7/66) 0.10 6.5%(12/184) 6.3% (1/16) 0.97
GD 7.5% (10/134) 16.7% (9/66) 0.16 8.2%(15/184) 25.0% (4/16) 0.02
HELLP 22.7% (30/132) 16.9% (11/65) 0.35 22.1% (40/181) 6.3% (1/16) 0.13
Severe 67.2% (88/131) 66.2%(43/65) 0.89 66.1% (119/180) 75% (12/16) 0.45
AKI 9.9% (13/131) 6.2%(4/65) 0.34 8.3% (15/180) 12.5% (2/16) 0.57
  1. UPE urinary protein excretion, HT Hypertension, BP Blood pressure in mmHg, PE Preeclampsia, AKI Acute kidney injury, GD gestational diabetes; f/u follow-up; d days